Fraser and Ablepharon macrostomia phenotypes: concurrence in one family and association with mutated FRAS1.
To date, Fraser syndrome (FS) and Ablepharon macrostomia syndrome (AMS) have been considered distinct disorders, but they share strikingly similar patterns of congenital abnormalities, specifically craniofacial anomalies. While recent research has led to the identification of the genes FRAS1 and FREM2 as the cause of FS, the genetic basis of AMS continues to be enigmatic. We report on the concurrence of AMS-like and Fraser phenotypes in a Brazilian family. Both affected sibs were homozygous for a novel splice site mutation in the FRAS1 gene. Extensive studies on mRNA expression indicated that this mutation most likely leads to loss of function as most previously reported FRAS1 mutations associated with FS. We conclude that a phenotype resembling AMS is a rare clinical expression of FS with no obvious genotype-phenotype correlation. However, the molecular basis of "true" AMS which has been reported as a sporadic disorder in all cases but one, and so far with no relation to FS, is probably different and still needs to be further investigated.
Cavalcanti
Denise Pontes
DP
Perinatal Genetic Program, Department of Medical Genetics, FCM, UNICAMP, Campinas, SP, Brazil.
Matejas
Verena
V
Luquetti
Daniela
D
Mello
Marcos Fernando
MF
Zenker
Martin
M
D000015:Abnormalities, Multiple / Q000235:genetics; D019465:Craniofacial Abnormalities / Q000235:genetics*; D016326:Extracellular Matrix Proteins / Q000235:genetics*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008265:Macrostomia / Q000150:complications* / Q000235:genetics; D008297:Male; D009154:Mutation; D010641:Phenotype; D050497:Stillbirth
D016326:Extracellular Matrix Proteins; C475145:FRAS1 protein, human